Peroxisome Proliferator-Activated Receptor-Review

References (66)

1. 1 An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) [DOI]
2. 2 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ [DOI]
3. 3 Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat [DOI]
4. 4 A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation [DOI]
5. 5 The PPARs: From Orphan Receptors to Drug Discovery [DOI]
6. 6 Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors [DOI]
7. 7 A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ [DOI]
8. 8 PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene. [DOI]
9. 9 Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. [DOI]
10. 10 Cross-Regulation of C/EBPα and PPARγ Controls the Transcriptional Pathway of Adipogenesis and Insulin Sensitivity [DOI]
11. 11 Differentiation and reversal of malignant changes in colon cancer through PPARγ [DOI]
12. 12 Sorting out the roles of PPAR in energy metabolism and vascular homeostasis [DOI]
13. 13 The Biology of Peroxisome Proliferator-Activated Receptors [DOI]
14. 14 PPARs: therapeutic targets for metabolic disease [DOI]
15. 15 PPAR : a dagger in the heart of the metabolic syndrome [DOI]
16. 16 Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists [DOI]
17. 17 Immunolocalization of peroxisome proliferator-activated receptors and retinoid x receptors in the adult rat CNS [DOI]
18. 18 Role of Oxidative Stress in Myocardial Hypertrophy and Failure [DOI]
19. 19 Regulation of PPARγ activity during adipogenesis [DOI]
20. 20 Pioglitazone Ameliorates Insulin Resistance and Diabetes by Both Adiponectin-dependent and -independent Pathways [DOI]
21. 21 PPARs in the brain [DOI]
22. 22 Rapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-α [DOI]
23. 23 Increased Lipid Oxidation Causes Oxidative Stress, Increased Peroxisome Proliferator-activated Receptor-γ Expression, and Diminished Pro-osteogenic Wnt Signaling in the Skeleton [DOI]
24. 24 Oxidized Alkyl Phospholipids Are Specific, High Affinity Peroxisome Proliferator-activated Receptor γ Ligands and Agonists [DOI]
25. 25 Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet [DOI]
26. 26 PPARα-Sirt1 Complex Mediates Cardiac Hypertrophy and Failure through Suppression of the ERR Transcriptional Pathway [DOI]
27. 27 ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation [DOI]
28. 28 Acute Intracerebroventricular Administration of Palmitoylethanolamide, an Endogenous Peroxisome Proliferator-Activated Receptor-α Agonist, Modulates Carrageenan-Induced Paw Edema in Mice [DOI]
29. 29 Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system [DOI]
30. 30 PPAR‐γ Activator Pioglitazone Prevents Age‐Related Atrial Fibrillation Susceptibility by Improving Antioxidant Capacity and Reducing Apoptosis in a Rat Model [DOI]
31. 31 Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses [DOI]
32. 32 p38 Mitogen-activated Protein Kinase Activates Peroxisome Proliferator-activated Receptor α [DOI]
33. 33 PPAR: a mediator of peroxisome proliferator action [DOI]
34. 34 Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging [DOI]
35. 35 Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies [DOI]
36. 36 Nuclear Factor-κB Activation Leads to Down-regulation of Fatty Acid Oxidation during Cardiac Hypertrophy [DOI]
37. 37 Expression and Localization of Peroxisome Proliferator-Activated Receptors and Nuclear Factor κB in Normal and Lesional Psoriatic Skin [DOI]
38. 38 Peroxisome Proliferator-Activated Receptor δ Is an Essential Transcriptional Regulator for Mitochondrial Protection and Biogenesis in Adult Heart [DOI]
39. 39 Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma [DOI]
40. 40 CARDIOMYOCYTIC APOPTOSIS FOLLOWING GLOBAL CARDIAC ISCHEMIA AND REPERFUSION CAN BE ATTENUATED BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α BUT NOT γ ACTIVATORS [DOI]
41. 41 PPARδ Coordinates Angiotensin II-induced Senescence in Vascular Smooth Muscle Cells through PTEN-mediated Inhibition of Superoxide Generation [DOI]
42. 42 Peroxisome Proliferator-activated Receptor δ Is Up-regulated during Vascular Lesion Formation and Promotes Post-confluent Cell Proliferation in Vascular Smooth Muscle Cells [DOI]
43. 43 PPARβ/δ potentiates PPARγ‐stimulated adipocyte differentiation [DOI]
44. 44 Pioglitazone Attenuates Tactile Allodynia and Thermal Hyperalgesia in Mice Subjected to Peripheral Nerve Injury [DOI]
45. 45 PPAR Ligands: Are They Potential Agents for Cardiovascular Disorders? [DOI]
46. 46 Ligand Specificity of Nuclear Hormone Receptors: Sifting through Promiscuity [DOI]
47. 47 New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines [DOI]
48. 48 Thioredoxin-1 and Its Natural Inhibitor, Vitamin D3 Up-Regulated Protein 1, Are Differentially Regulated by PPARα in Human Macrophages [DOI]
49. 49 Selective PPAR Agonists for the Treatment of Type 2 Diabetes [DOI]
50. 50 PPAR Research: Successful Launching and Promising Future [DOI]
51. 51 How mitochondria produce reactive oxygen species [DOI]
52. 52 Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ [DOI]
53. 53 PPARs and the complex journey to obesity [DOI]
54. 54 A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport [DOI]
55. 55 The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases [DOI]
56. 56 Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System [DOI]
57. 57 Involvement of PPAR nuclear receptors in tissue injury and wound repair [DOI]
58. 58 Glutathione Peroxidase 3 Mediates the Antioxidant Effect of Peroxisome Proliferator-Activated Receptor γ in Human Skeletal Muscle Cells [DOI]
59. 59 Peroxisome Proliferator-Activated Receptor-γ Ligands Reduce Neuronal Inducible Nitric Oxide Synthase Expression and Cell DeathIn Vivo [DOI]
60. 60 Peroxisome proliferator-activated receptor δ activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes [DOI]
61. 61 Intrathecal Rosiglitazone Acts at Peroxisome Proliferator–Activated Receptor-γ to Rapidly Inhibit Neuropathic Pain in Rats [DOI]
62. 62 The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation [DOI]
63. 63 In Vivo Activation of Peroxisome Proliferator-Activated Receptor-δ Protects the Heart from Ischemia/Reperfusion Injury in Zucker Fatty Rats [DOI]
64. 64 Effects of peroxisome proliferator activated receptors (PPAR)-γ and -α agonists on cochlear protection from oxidative stress [DOI]
65. 65 Clofibrate PPARα Activation Reduces Oxidative Stress and Improves Ultrastructure and Ventricular Hemodynamics in No-flow Myocardial Ischemia [DOI]
66. 66 Activation of PPARδ counteracts angiotensin II-induced ROS generation by inhibiting rac1 translocation in vascular smooth muscle cells [DOI]

Cited by 6

Showing 3 of 6 known citations — external sources report more than can currently be individually listed.

Related research

• Metabolic Syndrome among Healthcare Workers in a Tertiary Hospital in South-South, Nigeria — shares topic coverage
• Dietary Pattern and Prevalence of High Blood Pressure among Adult Traders in Port Harcourt, Nigeria — shares topic coverage
• Impact of the Diet Profile and Alcohol Consumption on Cardiometabolic Risks in Dschang Health District-Cameroon — shares topic coverage
• Gender Specific Predictive Performance and Optimal Threshold of Anthropometric Indices for the Prediction of Hypertension among a Ghanaian Population in Kumasi — shares topic coverage
• Metabolic Syndrome and Kidney Damage: Prevalence and Assessment of Risk among Apparently Healthy Resident of Ado Ekiti, South West Nigeria — shares topic coverage